₹371.30
▲ 5.71%
Delayed · as of 18 Aug 2026
Dividend per share by financial year
| Financial year | Total dividend |
|---|---|
| FY21 | ₹0.22 |
| FY22 | ₹0.93 |
| FY23 | ₹1.12 |
| FY24 | ₹0.63 |
| FY25 | ₹0.17 |
| FY26 | ₹0.67 |
Recent payouts
9 on record since FY21| Type | Amount (adjusted) | Ex-date | Record date | FY |
|---|---|---|---|---|
| FINAL | ₹0.67 | 04 Sep 2025 | ||
| FINAL | ₹0.17* | 15 Jul 2024 | ||
| INTERIM | ₹0.50* | 22 Feb 2024 | ||
| FINAL | ₹0.13* | 01 Sep 2023 | ||
| INTERIM | ₹0.59* | 02 Dec 2022 |
Amounts marked *were restated for a later split or bonus so they compare with today’s shares. Switch to “as filed” to see what was actually declared at the time — that is the figure on an old broker statement.
Against the marketIndex yields as of 17 Aug 2026+ Show– Hide
Index dividend yields are published by NSE alongside the closing levels. The dividend index is the fairer comparison: measured against the broad market almost every instrument here looks generous. A higher yield is not automatically better — it can mean a falling price as easily as a rising payout, which is what the chart above separates.
Yield through time
253 sessions · 07 Aug 2025 – 18 Aug 2026Trailing twelve-month payout divided by that session’s closing price, so a move here is either the payout changing or the price changing — the two readings a single current yield cannot tell apart. Ranged 0.00% to 0.30% over this window, ending at 0.18%. Closes and payouts are both split-adjusted, so a split does not appear as a change in yield. Tap or drag the chart to read a single session.
Other corporate actions2 on record+ Show– Hide
| Action | Ratio | Ex-date | Record date |
|---|---|---|---|
| Bonus issuehistory adjusted | 1:2 — 1 free share for every 2 held | 09 Aug 2024 | |
| Stock splithistory adjusted | 1:5 — one share became 5 | 10 Oct 2023 |
Splits and bonuses change the share count, so payouts declared before one are restated in the chart above to stay comparable. Buybacks, rights issues and mergers are listed for reference and do not affect those figures.
Others in Pharmaceuticals6 instruments+ Show– Hide
Ranked by published trailing-12-month yield. Classification is factual, not a recommendation.
Similar current yields
Same asset type, ordered by distance from this instrument’s published trailing-12-month yield. These are not business-sector peers or recommendations.